Trial Profile
Retrospective study assessing the efficacy of gefitinib treatment in patients with advanced adenocarcinoma of the lung
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Feb 2016
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary)
- Indications Adenocarcinoma; Lung cancer
- Focus Therapeutic Use
- 08 Feb 2016 New trial record